Literature DB >> 31582382

Palliative care within universal health coverage: the Malawi Patient-and-Carer Cancer Cost Survey.

S Bertel Squire1, Louis Niessen1, Maya Jane Bates2,1, Eve Namisango3, Ewan Tomeny1, Adamson Muula4.   

Abstract

OBJECTIVE: Evidence of the role of palliative care to reduce financial hardship and to support wellbeing in low/middle-income countries (LMIC) is growing, though standardised tools to capture relevant economic data are limited. We describe the development of the Patient-and-Carer Cancer Cost Survey (PaCCCt survey) which can be used to gather data on healthcare use and out-of-pocket expenditure (OOPE) in households affected by cancer in LMIC.
METHODS: To identify relevant content qualitative data were gathered using Photovoice to detail concepts of wellbeing and cost areas of importance in households receiving palliative care in Blantyre, Malawi. Existing approaches and tools used to capture OOPE were mapped through a review of the literature. The WHO tuberculosis patient cost survey was chosen for adaptation. Face and content validity of a zero-draft of the PaCCCt survey were developed through review by healthcare professionals and a national stakeholder group. The final survey was translated into local language (Chichewa) and piloted.
RESULTS: The PaCCCt survey is a tablet-based, third-party administered survey recording healthcare service utilisation and related direct and indirect costs. Coping strategies (loans and dissaving and so on), funeral costs and wellbeing at household level are included. Completion time is <30 min.
CONCLUSION: The PaCCCt survey can be used as part of economic evaluations in populations in need of palliative care in LMIC. Such evidence can support calls for the inclusion of palliative care within Universal Health Coverage which requires end-user protection from financial hardship. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  cost and cost analysis; developing country; family caregivers; neoplasms; palliative care

Year:  2019        PMID: 31582382     DOI: 10.1136/bmjspcare-2019-001945

Source DB:  PubMed          Journal:  BMJ Support Palliat Care        ISSN: 2045-435X            Impact factor:   3.568


  5 in total

1.  Protocol for a prospective cohort study of open tibia fractures in Malawi with a nested implementation of open fracture guidelines.

Authors:  Alexander Thomas Schade; Nohakhelha Nyamulani; Leonard Ngoe Banza; Andrew John Metcalfe; Andrew Leather; Jason J Madan; David G Lallloo; Williams James Harrison; Peter MacPherson
Journal:  Wellcome Open Res       Date:  2021-09-13

2.  Study protocol for a single-centre observational study of household wellbeing and poverty status following a diagnosis of advanced cancer in Blantyre, Malawi - 'Safeguarding the Family' study.

Authors:  Maya Jane Bates; Adamson Muula; Stephen B Gordon; Marc Y R Henrion; Ewan Tomeny; Peter MacPherson; Bertel Squire; Louis Niessen
Journal:  Wellcome Open Res       Date:  2020-03-02

3.  Impact, challenges and limits of inpatient palliative care consultations - perspectives of requesting and conducting physicians.

Authors:  Anja Coym; Karin Oechsle; Alena Kanitz; Nora Puls; David Blum; Carsten Bokemeyer; Anneke Ullrich
Journal:  BMC Health Serv Res       Date:  2020-02-04       Impact factor: 2.655

4.  Palliative care and catastrophic costs in Malawi after a diagnosis of advanced cancer: a prospective cohort study.

Authors:  Maya Jane Bates; Miriam R P Gordon; Stephen B Gordon; Ewan M Tomeny; Adamson S Muula; Helena Davies; Claire Morris; Gerald Manthalu; Eve Namisango; Leo Masamba; Marc Y R Henrion; Peter MacPherson; S Bertel Squire; Louis W Niessen
Journal:  Lancet Glob Health       Date:  2021-10-29       Impact factor: 38.927

5.  Data and information needs of policymakers for palliative cancer care: a multi-country qualitative study.

Authors:  Eve Namisango; Lauren Ramsey; Adlight Dandadzi; Kehinde Okunade; Bassey Ebenso; Matthew J Allsop
Journal:  BMC Med Inform Decis Mak       Date:  2021-06-15       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.